RemeGen Statistics

Total Valuation

RemeGen has a market cap or net worth of CNY 20.05 billion. The enterprise value is 21.65 billion.

Market Cap	20.05B
Enterprise Value	21.65B

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.38%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	339.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	9.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.75
EV / Sales	12.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	1.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.56% and return on invested capital (ROIC) is -18.86%.

Return on Equity (ROE)	-50.56%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-18.86%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	474,524
Profits Per Employee	-406,048
Employee Count	3,615
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.38% in the last 52 weeks. The beta is 0.41, so RemeGen's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-18.38%
50-Day Moving Average	31.60
200-Day Moving Average	31.99
Relative Strength Index (RSI)	77.40
Average Volume (20 Days)	4,931,744

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RemeGen had revenue of CNY 1.72 billion and -1.47 billion in losses. Loss per share was -2.73.

Revenue	1.72B
Gross Profit	1.72B
Operating Income	-1.45B
Pretax Income	-1.47B
Net Income	-1.47B
EBITDA	-1.28B
EBIT	-1.45B
Loss Per Share	-2.73

Full Income Statement

Balance Sheet

The company has 925.14 million in cash and 2.53 billion in debt, giving a net cash position of -1.61 billion.

Cash & Cash Equivalents	925.14M
Total Debt	2.53B
Net Cash	-1.61B
Net Cash Per Share	n/a
Equity (Book Value)	2.37B
Book Value Per Share	4.40
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -84.43% and -85.57%.

Gross Margin	100.00%
Operating Margin	-84.43%
Pretax Margin	-85.57%
Profit Margin	-85.57%
EBITDA Margin	-74.40%
EBIT Margin	-84.43%
FCF Margin	n/a

Dividends & Yields

RemeGen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.38%
Shareholder Yield	0.38%
Earnings Yield	-7.32%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a